Effects of repeated milnacipran administration on brain serotonergic and noradrenergic functions in healthy volunteers.
Soya
Atsushi
A
Terao
Takeshi
T
Nakajima
Mami
M
Kojima
Hideki
H
Okamoto
Tatsuya
T
Inoue
Yoshiaki
Y
Iwakawa
Miki
M
Shinkai
Koji
K
Yoshimura
Reiji
R
Ueta
Yoichi
Y
Nakamura
Jun
J
D018759:Adrenergic Uptake Inhibitors / Q000494:pharmacology*; D000324:Adrenocorticotropic Hormone / Q000097:blood; D000328:Adult; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D003521:Cyclopropanes / Q000008:administration & dosage / Q000494:pharmacology*; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D006801:Humans; D008297:Male; D008875:Middle Aged; D000078764:Milnacipran; D009638:Norepinephrine / Q000378:metabolism*; D017374:Paroxetine / Q000008:administration & dosage; D012016:Reference Values; D012701:Serotonin / Q000378:metabolism*; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology*; D013997:Time Factors
D018759:Adrenergic Uptake Inhibitors; D000324:Adrenocorticotropic Hormone; D003521:Cyclopropanes; D000078764:Milnacipran; D009638:Norepinephrine; D017374:Paroxetine; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors